Safety and Efficacy of Combined Extracorporeal CO2 Removal and Renal Replacement Therapy in Patients With Acute Respiratory Distress Syndrome and Acute Kidney Injury: The Pulmonary and Renal Support in Acute Respiratory Distress Syndrome Study

Jérôme Allardet-Servent, Matthias Castanier, Thomas Signouret, Rettinavelou Soundaravelou, Anne Lepidi, Jean-Marie Seghboyan, Jérôme Allardet-Servent, Matthias Castanier, Thomas Signouret, Rettinavelou Soundaravelou, Anne Lepidi, Jean-Marie Seghboyan

Abstract

Objective: To assess the safety and efficacy of combining extracorporeal CO2 removal with continuous renal replacement therapy in patients presenting with acute respiratory distress syndrome and acute kidney injury.

Design: Prospective human observational study.

Settings: Patients received volume-controlled mechanical ventilation according to the acute respiratory distress syndrome net protocol. Continuous venovenous hemofiltration therapy was titrated to maintain maximum blood flow and an effluent flow of 45 mL/kg/h with 33% predilution.

Patients: Eleven patients presenting with both acute respiratory distress syndrome and acute kidney injury required renal replacement therapy.

Interventions: A membrane oxygenator (0.65 m) was inserted within the hemofiltration circuit, either upstream (n = 7) or downstream (n = 5) of the hemofilter. Baseline corresponded to tidal volume 6 mL/kg of predicted body weight without extracorporeal CO2 removal. The primary endpoint was 20% reduction in PaCO2 at 20 minutes after extracorporeal CO2 removal initiation. Tidal volume was subsequently reduced to 4 mL/kg for the remaining 72 hours.

Measurements and main results: Twelve combined therapies were conducted in the 11 patients. Age was 70 ± 9 years, Simplified Acute Physiology Score II was 69 ± 13, Sequential Organ Failure Assessment score was 14 ± 4, lung injury score was 3 ± 0.5, and PaO2/FIO2 was 135 ± 41. Adding extracorporeal CO2 removal at tidal volume 6 mL/kg decreased PaCO2 by 21% (95% CI, 17-25%), from 47 ± 11 to 37 ± 8 Torr (p < 0.001). Lowering tidal volume to 4 mL/kg reduced minute ventilation from 7.8 ± 1.5 to 5.2 ± 1.1 L/min and plateau pressure from 25 ± 4 to 21 ± 3 cm H2O and raised PaCO2 from 37 ± 8 to 48 ± 10 Torr (all p < 0.001). On an average of both positions, the oxygenator's blood flow was 410 ± 30 mL/min and the CO2 removal rate was 83 ± 20 mL/min. The oxygenator blood flow (p <0.001) and the CO2 removal rate (p = 0.083) were higher when the membrane oxygenator was placed upstream of the hemofilter. There was no safety concern.

Conclusions: Combining extracorporeal CO2 removal and continuous venovenous hemofiltration in patients with acute respiratory distress syndrome and acute kidney injury is safe and allows efficient blood purification together with enhanced lung protective ventilation.

Conflict of interest statement

Dr. Allardet-Servent’s institution received grant support from ARARD (contribution to the paiement of membrane oxygenator). The remaining authors have disclosed that they do not have any potential conflicts of interest.

Figures

Figure 1.
Figure 1.
Individual changes in Paco2 between baseline and 20 min after ECCo2R initiation (p < 0.001) at constant tidal volume (6 mL/kg predicted body weight).
Figure 2.
Figure 2.
Time course of Paco2 (A) and pH (B) during the study period; *p < 0.05 vs baseline; †p < 0.05 vs 20 min (M20); £p < 0.05 vs 1 hr (H1).
Figure 3.
Figure 3.
Time course of tidal volume (VT; A), minute ventilation (B), plateau pressure (Pplat; C), and positive end-expiratory pressure (PEEP; D) during the study period; *p < 0.05 vs baseline; †p < 0.05 vs 20 min (M20). .VE = minute ventilation.
Figure 4.
Figure 4.
Time course of the total rate of Co2 elimination (total Vco2) with respective contribution of the Vco2 by the natural lung and the Vco2 by the membrane oxygenator; p = NS for total Vco2 (Tables 4 and 5 for Vco2Lung and Vco2Oxy variations, respectively). Note that the total Vco2 increased at 20 min (M20) due to additional Co2 removal provided by the membrane oxygenator. Also note that the total Vco2 decreased at 1 hr (H1) due to the reduction of tidal volume from 6 to 4 mL/kg predicted body weight, with values similar to baseline.
Figure 5.
Figure 5.
Time course of the oxygenator blood flow (A) and Co2 removal rate by the membrane oxygenator (B) during the study period according to the position of the membrane oxygenator within the renal replacement therapy circuit (upstream of hemofilter [HF] or downstream of HF); *p < 0.05 between positions; †p < 0.05 vs 20 min (M20); £p < 0.05 vs 1 hr (H1).

References

    1. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353:1685–1693.
    1. Brun-Buisson C, Minelli C, Bertolini G, et al. ALIVE Study Group. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med. 2004;30:51–61.
    1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334–1349.
    1. Rouby JJ, Puybasset L, Nieszkowska A, et al. Acute respiratory distress syndrome: Lessons from computed tomography of the whole lung. Crit Care Med. 2003;31:S285–S295.
    1. Gattinoni L, Pesenti A. The concept of “baby lung”. Intensive Care Med. 2005;31:776–784.
    1. Nieszkowska A, Lu Q, Vieira S, et al. Incidence and regional distribution of lung overinflation during mechanical ventilation with positive end-expiratory pressure. Crit Care Med. 2004;32:1496–1503.
    1. Terragni PP, Rosboch G, Tealdi A, et al. Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2007;175:160–166.
    1. Caironi P, Cressoni M, Chiumello D, et al. Lung opening and closing during ventilation of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2010;181:578–586.
    1. Chiumello D, Carlesso E, Cadringher P, et al. Lung stress and strain during mechanical ventilation for acute respiratory distress syndrome. Am J Respir Crit Care Med. 2008;178:346–355.
    1. Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369:2126–2136.
    1. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–1308.
    1. Conrad SA, Zhang S, Arnold TC, et al. Protective effects of low respiratory frequency in experimental ventilator-associated lung injury. Crit Care Med. 2005;33:835–840.
    1. Vaporidi K, Voloudakis G, Priniannakis G, et al. Effects of respiratory rate on ventilator-induced lung injury at a constant Paco2 in a mouse model of normal lung. Crit Care Med. 2008;36:1277–1283.
    1. Rich PB, Reickert CA, Sawada S, et al. Effect of rate and inspiratory flow on ventilator-induced lung injury. J Trauma. 2000;49:903–911.
    1. Rich PB, Douillet CD, Hurd H, et al. Effect of ventilatory rate on airway cytokine levels and lung injury. J Surg Res. 2003;113:139–145.
    1. Garcia CS, Abreu SC, Soares RM, et al. Pulmonary morphofunctional effects of mechanical ventilation with high inspiratory air flow. Crit Care Med. 2008;36:232–239.
    1. Hager DN, Krishnan JA, Hayden DL, et al. ARDS Clinical Trials Network. Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med. 2005;172:1241–1245.
    1. Hickling KG, Wright T, Laubscher K, et al. Extreme hypoventilation reduces ventilator-induced lung injury during ventilation with low positive end-expiratory pressure in saline-lavaged rabbits. Crit Care Med. 1998;26:1690–1697.
    1. Fuchs H, Mendler MR, Scharnbeck D, et al. Very low tidal volume ventilation with associated hypercapnia–effects on lung injury in a model for acute respiratory distress syndrome. PLoS One. 2011;6:e23816.
    1. Frank JA, Gutierrez JA, Jones KD, et al. Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. Am J Respir Crit Care Med. 2002;165:242–249.
    1. Bein T, Weber-Carstens S, Goldmann A, et al. Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDS: The prospective randomized Xtravent-study. Intensive Care Med. 2013;39:847–856.
    1. Terragni PP, Del Sorbo L, Mascia L, et al. Tidal volume lower than 6 ml/kg enhances lung protection: Role of extracorporeal carbon dioxide removal. Anesthesiology. 2009;111:826–835.
    1. Rubenfeld GD, Cooper C, Carter G, et al. Barriers to providing lung-protective ventilation to patients with acute lung injury. Crit Care Med. 2004;32:1289–1293.
    1. Kolobow T, Gattinoni L, Tomlinson TA, et al. Control of breathing using an extracorporeal membrane lung. Anesthesiology. 1977;46:138–141.
    1. Gattinoni L, Kolobow T, Tomlinson T, et al. Low-frequency positive pressure ventilation with extracorporeal carbon dioxide removal (LFPPV-ECCO2R): An experimental study. Anesth Analg. 1978;57:470–477.
    1. Cove ME, MacLaren G, Federspiel WJ, et al. Bench to bedside review: Extracorporeal carbon dioxide removal, past present and future. Crit Care. 2012;16:232.
    1. Fitzgerald M, Millar J, Blackwood B, et al. Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: A systematic review. Crit Care. 2014;18:222.
    1. Liu KD, Glidden DV, Eisner MD, et al. National Heart, Lung, and Blood Institute ARDS Network Clinical Trials Group. Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. Crit Care Med. 2007;35:2755–2761.
    1. Soto GJ, Frank AJ, Christiani DC, et al. Body mass index and acute kidney injury in the acute respiratory distress syndrome. Crit Care Med. 2012;40:2601–2608.
    1. KDIGO Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.
    1. Uchino S, Kellum JA, Bellomo R, et al. Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA. 2005;294:813–818.
    1. Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: The Berlin Definition. JAMA. 2012;307:2526–2533.
    1. Joannidis M, Oudemans-van Straaten HM. Clinical review: Patency of the circuit in continuous renal replacement therapy. Crit Care. 2007;11:218.
    1. Livigni S, Maio M, Ferretti E, et al. Efficacy and safety of a low-flow veno-venous carbon dioxide removal device: Results of an experimental study in adult sheep. Crit Care. 2006;10:R151.
    1. Forster C, Schriewer J, John S, et al. Low-flow CO2 removal integrated into a renal-replacement circuit can reduce acidosis and decrease vasopressor requirements. Crit Care. 2013;17:R154.
    1. Batchinsky AI, Jordan BS, Regn D, et al. Respiratory dialysis: Reduction in dependence on mechanical ventilation by venovenous extracorporeal CO2 removal. Crit Care Med. 2011;39:1382–1387.
    1. Grasso S, Stripoli T, Mazzone P, et al. Low respiratory rate plus minimally invasive extracorporeal Co2 removal decreases systemic and pulmonary inflammatory mediators in experimental Acute Respiratory Distress Syndrome. Crit Care Med. 2014;42:e451–e460.
    1. Hoffmann JN, Hartl WH, Deppisch R, et al. Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med. 1996;22:1360–1367.
    1. Cole L, Bellomo R, Journois D, et al. High-volume haemofiltration in human septic shock. Intensive Care Med. 2001;27:978–986.
    1. Richard JC, Maggiore SM, Jonson B, et al. Influence of tidal volume on alveolar recruitment. Respective role of PEEP and a recruitment maneuver. Am J Respir Crit Care Med. 2001;163:1609–1613.
    1. Retamal J, Libuy J, Jiménez M, et al. Preliminary study of ventilation with 4 ml/kg tidal volume in acute respiratory distress syndrome: Feasibility and effects on cyclic recruitment - derecruitment and hyperinflation. Crit Care. 2013;17:R16.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться